The Global Retinoblastoma Outcome Study | A prospective, cluster-based analysis of 4,064 patients from 149 countries.

The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries – The Lancet Global Health

Invited Commentary: Retinoblastoma as a lens for correctable disparities worldwide – The Lancet Global Health

News Release: Children in low-income countries 16 times more likely to die from most common eye cancer – London School of Hygiene & Tropical Medicine